Implementation of the ESC 0 h/1 h high-sensitivity troponin algorithm for decision-making in the emergency department
Maria Rubini Gimenez1, Jasper Boeddinghaus2, Thomas Nestelberger3
1Department of Cardiology and internal Medicine, University Heart Center Leipzig, Leipzig, Germany; Cardiovascular Research Institute of Basel, University Hospital Basel, Basel, Switzerland.
Insights
High-sensitivity cardiac troponin (hs-cTn) assays significantly improve early detection of non-ST-segment elevation acute coronary syndromes (NSTEACS). These advanced troponin tests enable faster diagnosis, aiding in quicker patient assessment and treatment decisions.
Area of Science:
- Cardiology
- Biomarker Discovery
- Diagnostic Assays
Background:
- Non-ST-segment elevation acute coronary syndromes (NSTEACS) diagnosis relies on clinical presentation, ECG, and cardiac troponin.
- Traditional troponin assays have limitations in speed and sensitivity for early detection.
Purpose of the Study:
- To provide an overview of high-sensitivity cardiac troponin (hs-cTn) assays in the early detection of NSTEACS.
- To highlight the role of hs-cTn in current diagnostic guidelines and clinical practice.
Main Methods:
- Review of current literature and guidelines on hs-cTn assay implementation.
- Analysis of the impact of hs-cTn on diagnostic timelines and patient management.
Main Results:
- hs-cTn assays enhance the detection of cardiomyocyte injury, enabling earlier diagnosis.
- These assays facilitate faster "rule-out" and more rapid "rule-in" for NSTEACS.
- Rapid diagnostic algorithms utilizing serial hs-cTn sampling are recommended.
Conclusions:
- hs-cTn assays are the gold standard for assessing patients with suspected NSTEACS.
- Implementation of hs-cTn assays improves diagnostic efficiency and patient care pathways.
- The use of hs-cTn is crucial for timely and accurate NSTEACS diagnosis.
Abstract:
Diagnosis of non-ST-segment elevation acute coronary syndromes (NSTEACS) is based on 3 cornerstones: clinical presentation, 12-lead electrocardiogram, and cardiac troponin measurement. Advances in the development of high-sensitivity cardiac troponin (hs-cTn) assays have substantially improved the detection of cardiomyocyte injury in a shorter time period, and hs-cTn has consequently been established as the gold-standard biomarker for the assessment of patients with suspected NSTEACS. The implementation of these assays in clinical practice allows a faster "rule-out", especially among low-risk patients, as well as a safer and more rapid "rule-in", with its therapeutic consequences. Current guidelines for the diagnosis of NSTEACS recommend the use of hs-cTn applied in rapid diagnostic algorithms based on serial hs-cTn sampling within the first few hours. The current work provides an overview of the use of hs-cTn for the early detection of NSTEACS.
More Related Videos
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Introduction Cardiac Emergencies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
